F. Turon

J. González-Navajas, F. Tomás-Barberán, J. García‐Pagán, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.

D. Colomer, D. Valla, N. Casadevall, 2017, Journal of hepatology.

Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis

D. Valla, J. Trebicka, H. Janssen, 2015, Haematologica.

Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.

D. Colomer, J. García‐Pagán, V. Hernández-Gea, 2015, Journal of hepatology.

The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.

J. Fuster, J. García-Valdecasas, G. Martínez-Pallí, 2019, Journal of hepatology.

Budd-Chiari Syndrome: Hepatic Venous Outflow Tract Obstruction

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis

J. García‐Pagán, Arturo Pereira, V. Hernández-Gea, 2020, Annals of Hematology.

Congenital antithrombin deficiency in patients with splanchnic vein thrombosis

J. Corral, V. Vicente, J. García‐Pagán, 2019, Liver international : official journal of the International Association for the Study of the Liver.

New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis

J. García‐Pagán, V. Hernández-Gea, M. Burrel, 2020, Seminars in Thrombosis and Hemostasis.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

H. Møller, H. Grønbaek, J. García‐Pagán, 2021, Frontiers in Physiology.

Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome.

D. Valla, C. Bureau, E. de Raucourt, 2018, Journal of hepatology.

Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.

J. Bosch, Hélène Larrue, C. Bureau, 2022, Journal of hepatology.

Best Practice & Research Clinical Gastroenterology

J. García‐Pagán, S. Casu, F. Turon, 2013 .

A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.

P. Tandon, A. Berzigotti, J. Genescà, 2014, Gastroenterology.

Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2015, Journal of hepatology.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.

J. Lozano, J. García‐Pagán, S. Seijo, 2021, Journal of hepatology.

Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis

J. Balust, G. Martínez-Pallí, A. Berzigotti, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Unexpected disappearance of portal cavernoma on long-term anticoagulation.

J. García‐Pagán, V. Hernández-Gea, Á. García-Criado, 2014, Journal of hepatology.

Congenital Extrahepatic Portosystemic Shunts: Abernethy Malformation

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

Nontumoral portal vein thrombosis in patients awaiting liver transplantation

C. Fondevila, J. Fuster, J. García-Valdecasas, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study

J. García‐Pagán, V. Hernández-Gea, T. Lisman, 2022, Journal of thrombosis and haemostasis : JTH.

Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.

R. Borrás, A. Berzigotti, J. García‐Pagán, 2021, Journal of hepatology.

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, Clinical Gastroenterology and Hepatology.

Reply to: ''Splenic artery aneurysms, portal hypertension and pregnancy".

C. Bureau, F. Oberti, J. García‐Pagán, 2019, Journal of hepatology.

Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

A. Villanueva, A. Berzigotti, V. Hernández-Gea, 2013, World journal of gastroenterology.

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

J. Lozano, A. Berzigotti, C. Alonso, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastography.

A. Berzigotti, I. Araujo, J. Abraldes, 2012, Gastroenterologia y hepatologia.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

M. Pavesi, V. Arroyo, P. Ginès, 2012, Journal of hepatology.

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.

M. Ronot, V. Vilgrain, J. García‐Pagán, 2019, Journal of hepatology.

Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

M. Juan, J. García‐Pagán, S. Seijo, 2021, Liver international : official journal of the International Association for the Study of the Liver.

The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

H. Møller, T. Sandahl, H. Grønbæk, 2016, Alimentary pharmacology & therapeutics.

Metabolomics as a diagnostic tool for idiopathic non‐cirrhotic portal hypertension

M. Martínez-Chantar, J. Lozano, A. Berzigotti, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

M. Poca, J. Calleja, J. Lozano, 2023, Hepatology.

Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension

D. Valla, J. Trebicka, J. Nault, 2016, Hepatology.

Portal vein thrombosis: yes or no on anticoagulation therapy.

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2018, Current opinion in organ transplantation.

Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response

X. Forns, G. Casanovas, J. García‐Pagán, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Reply to: Correspondence on "Predicting portal thrombosis in cirrosis: A prospective study of clinical, ultrasonographic and hemostatic factors".

T. Lisman, F. Turon, Juan Carlos-Garcia-Pagan, 2021, Journal of hepatology.

Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.

J. García‐Pagán, J. Bosch, F. Torres, 2017, Gastroenterology.

[Early transjugular intrahepatic portosystemic shunt: When, how and in whom?].

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2016, Gastroenterologia y hepatologia.

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

J. Ampuero, G. Casanovas, J. Genescà, 2023, Journal of Hepatology.

Non‐invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

F. Nigsch, X. Forns, C. Ukomadu, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Reply to: "Calreticulin mutations and their importance in Budd-Chiari syndrome".

D. Valla, J. García‐Pagán, C. Marzac, 2017, Journal of hepatology.

M. Pavesi, V. Arroyo, M. Guevara, 2012, Journal of hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, J. García‐Pagán, J. Genescà, 2017, Gastroenterologia y hepatologia.

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

A. de Gottardi, D. Semela, D. Valla, 2017, Liver international : official journal of the International Association for the Study of the Liver.